224 related articles for article (PubMed ID: 20193080)
1. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.
Senchenko VN; Anedchenko EA; Kondratieva TT; Krasnov GS; Dmitriev AA; Zabarovska VI; Pavlova TV; Kashuba VI; Lerman MI; Zabarovsky ER
BMC Cancer; 2010 Mar; 10():75. PubMed ID: 20193080
[TBL] [Abstract][Full Text] [Related]
2. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
[TBL] [Abstract][Full Text] [Related]
4. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.
Agathanggelou A; Bièche I; Ahmed-Choudhury J; Nicke B; Dammann R; Baksh S; Gao B; Minna JD; Downward J; Maher ER; Latif F
Cancer Res; 2003 Sep; 63(17):5344-51. PubMed ID: 14500366
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.
Li J; Wang F; Haraldson K; Protopopov A; Duh FM; Geil L; Kuzmin I; Minna JD; Stanbridge E; Braga E; Kashuba VI; Klein G; Lerman MI; Zabarovsky ER
Cancer Res; 2004 Sep; 64(18):6438-43. PubMed ID: 15374952
[TBL] [Abstract][Full Text] [Related]
8. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.
Kashuba VI; Li J; Wang F; Senchenko VN; Protopopov A; Malyukova A; Kutsenko AS; Kadyrova E; Zabarovska VI; Muravenko OV; Zelenin AV; Kisselev LL; Kuzmin I; Minna JD; Winberg G; Ernberg I; Braga E; Lerman MI; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4906-11. PubMed ID: 15051889
[TBL] [Abstract][Full Text] [Related]
9. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
11. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.
Kashuba VI; Pavlova TV; Grigorieva EV; Kutsenko A; Yenamandra SP; Li J; Wang F; Protopopov AI; Zabarovska VI; Senchenko V; Haraldson K; Eshchenko T; Kobliakova J; Vorontsova O; Kuzmin I; Braga E; Blinov VM; Kisselev LL; Zeng YX; Ernberg I; Lerman MI; Klein G; Zabarovsky ER
PLoS One; 2009 May; 4(5):e5231. PubMed ID: 19478941
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
Endoh H; Yatabe Y; Shimizu S; Tajima K; Kuwano H; Takahashi T; Mitsudomi T
Int J Cancer; 2003 Aug; 106(1):45-51. PubMed ID: 12794755
[TBL] [Abstract][Full Text] [Related]
13. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
Agathanggelou A; Honorio S; Macartney DP; Martinez A; Dallol A; Rader J; Fullwood P; Chauhan A; Walker R; Shaw JA; Hosoe S; Lerman MI; Minna JD; Maher ER; Latif F
Oncogene; 2001 Mar; 20(12):1509-18. PubMed ID: 11313894
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.
Burbee DG; Forgacs E; Zöchbauer-Müller S; Shivakumar L; Fong K; Gao B; Randle D; Kondo M; Virmani A; Bader S; Sekido Y; Latif F; Milchgrub S; Toyooka S; Gazdar AF; Lerman MI; Zabarovsky E; White M; Minna JD
J Natl Cancer Inst; 2001 May; 93(9):691-9. PubMed ID: 11333291
[TBL] [Abstract][Full Text] [Related]
15. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.
Li J; Zhang Z; Dai Z; Popkie AP; Plass C; Morrison C; Wang Y; You M
Neoplasia; 2003; 5(4):362-6. PubMed ID: 14511407
[TBL] [Abstract][Full Text] [Related]
17. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.
Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li J; Kashuba V; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7504-9. PubMed ID: 11390984
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
19. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.
da Costa Prando E; Cavalli LR; Rainho CA
Epigenetics; 2011 Dec; 6(12):1413-24. PubMed ID: 22139571
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
